rtmark
LearnBonds.com

What Are Analysts Expecting from Aurora Cannabis’ Earnings

aurora cannabis

The earnings season is in full swing. Aurora Cannabis has scheduled its quarterly earnings for tomorrow. Here’s what analysts are projecting for the company’s earnings.

Cannabis company Canopy Growth reported its quarterly earnings yesterday that propelled its stock higher. The company’s earnings coupled with Tilray’s deal with a UK company to distribute its medical marijuana products in the country led to a sharp rise in all cannabis stocks. Aurora Cannabis gained almost 5% yesterday and was trading sharply over 11% higher in US premarket trading today.

What’re analysts projecting for Aurora Cannabis’ earnings

Aurora Cannabis would report its fiscal second quarter 2021 earnings on Thursday. Analysts expect the company’s revenues to rise 23% year over year in the quarter to $69 million. The company’s revenues had fallen on a yearly basis in the previous two quarters as the pandemic situation took a toll on its performance.

Aurora Cannabis expected to post a loss

Analysts expect Aurora Cannabis to post an adjusted EBITDA of -$5.3 billion in the quarter. Analysts expect it to post negative EBITDA in the March quarter also but start posting positive EBITDA thereafter. Notably, most cannabis companies are making losses on the EBITDA level, let alone posting a net profit.

Canopy Growth expects to be EBITDA positive next year

That said, most of the high growth companies across tech and green energy space are currently posting losses. Investors have been more concerned about the topline growth that these companies report. Meanwhile, cannabis companies have been trying hard to cut their losses and cash burn. During their earnings call, Canopy Growth said that it expects to post positive EBITDA in the second half of 2022 even as it talked about achieving cost savings of $150-$200 million over the next 12-18 months.

Cannabis industry at a tipping point

Aurora Cannabis CEO Miguel Martin told CNBC in an interview that the cannabis industry in the US is at a tipping point. Joe Biden’s election as the US president coupled with Democrats taking the control of the Senate have raised hopes of federal legalization of marijuana in the US.

While many US states have decriminalized marijuana, some have still not legalized recreational marijuana. Federal legalization of adult-use cannabis can drive the sales of cannabis companies.

What are analysts forecasting?

According to the estimates compiled by TipRanks, Aurora Cannabis has an average one-year price target of $8.55 which is 45.2% downside over its current prices. The stock’s lowest price target is $3.61 while its highest price target is $13.38. Aurora Cannabis stock was trading at $17.50 in US premarket trading today which is even higher than its highest price target. Of the 11 analysts covering the stock, seven rate it as a hold while the remaining four rate it as a sell. None of the analysts have a buy rating on the stock.

Aurora Cannabis valuation

Since Aurora Cannabis is not posting profits, we would need to value it based on the revenues. The stock currently trades at an NTM enterprise value to sales multiple of 13.7x which is almost double what it traded last year before the US presidential elections. However, markets are euphoric about marijuana stocks expecting federal legalization in the US.

How to buy Aurora Cannabis stock

You can trade in Aurora Cannabis stock through any of the reputed online stockbrokers. Alternatively, if you wish to trade derivatives, we also have reviewed a list of derivative brokers you can consider.

An alternative approach to investing in the cannabis company could be to invest in ETFs that invest in marijuana companies

Through a marijuana ETF, you can diversify your risks across many companies instead of just investing in a few companies. While this may mean that you might miss out on “home runs” you would also not end up owning the worst performing stocks in your portfolio. The AdvisorShares Pure Cannabis ETF (YOLO) is one ETF that invests in marijuana companies.

By investing in an ETF, one gets returns that are linked to the underlying index after accounting for the fees and other transaction costs. There is also a guide on how to trade in ETFs

Trusted & Regulated Stock & CFD Brokers

Rating

What we like

  • 0% Fees on Stocks
  • 5000+ Stocks, ETFs and other Markets
  • Accepts Paypal Deposits

Min Deposit

$200

Charge per Trade

Zero Commission

Rating

64 traders signed up today

Visit Now

75% of investors lose money when trading CFDs.

Available Assets

  • Total Number of Stocks & Shares5000+
  • US Stocks
  • German Stocks
  • UK Stocks
  • European
  • ETF Stocks
  • IPO
  • Funds
  • Bonds
  • Options
  • Futures
  • CFDs
  • Crypto

Charge per Trade

  • FTSE 100 Zero Commission
  • NASDAQ Zero Commission
  • DAX Zero Commission
  • Facebook Zero Commission
  • Alphabet Zero Commission
  • Tesla Zero Commission
  • Apple Zero Commission
  • Microsoft Zero Commission

Deposit Method

  • Wire Transfer
  • Credit Cards
  • Bank Account
  • Paypall
  • Skrill
  • Neteller

Rating

What we like

  • Sign up today and get $5 free
  • Fractals Available
  • Paypal Available

Min Deposit

$0

Charge per Trade

$1 to $9 PCM

Rating

Visit Now

Investing in financial markets carries risk, you have the potential to lose your total investment.

Available Assets

  • Total Number of Shares999
  • US Stocks
  • German Stocks
  • UK Stocks
  • European Stocks
  • EFTs
  • IPOs
  • Funds
  • Bonds
  • Options
  • Futures
  • CFDs
  • Crypto

Charge per Trade

  • FTSE 100 $1 - $9 per month
  • NASDAQ $1 - $9 per month
  • DAX $1 - $9 per month
  • Facebook $1 - $9 per month
  • Alphabet $1 - $9 per month
  • Telsa $1 - $9 per month
  • Apple $1 - $9 per month
  • Microsoft $1 - $9 per month

Deposit Method

  • Wire Transfer
  • Credit Cards
  • Bank Account
Users should remember that all trading carries risks and users should only invest in regulated firms. Views expressed are those of the writers only. Past performance is no guarantee of future results. The opinions expressed in this Site do not constitute investment advice and independent financial advice should be sought where appropriate. This website is free for you to use but we may receive commission from the companies we feature on this site.
Mohit Oberoi

Mohit Oberoi is a freelance finance writer based in India. he has completed his MBA with finance as majors and also holds a CFA charter. He has over 13 years of experience in financial markets. He has been writing extensively on global markets for the last six years and has written over 6,500 articles. He mainly covers metals, electric vehicles, asset managers, and other macroeconomic news. He also loves writing on personal finance and topics related to valuation.